The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Enzo Biochem's Revenue for the
three
months ended in Jan. 2024 was $8.55 Mil. Enzo Biochem's average Accounts Receivable for the
three
months ended in Jan. 2024 was $4.65 Mil.
Hence, Enzo Biochem's Receivables Turnover for the
three
months ended in Jan. 2024 was 1.84.
Enzo Biochem Receivables Turnover Historical Data
The historical data trend for Enzo Biochem's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's Receivables Turnover
For the Diagnostics & Research subindustry, Enzo Biochem's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's Receivables Turnover Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's Receivables Turnover falls into.
Enzo Biochem Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Enzo Biochem's Receivables Turnover for the fiscal year that ended in Jul. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Enzo Biochem Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 